Codes / ICD10CM / T50.991D

T50.991D Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter (ICD-10 Code: T50.991D)

Summary

This condition represents an accidental (unintentional) poisoning by drugs, medicaments, or biological substances not classified under more specific codes, occurring during a subsequent encounter. It includes harmful effects from exposure to these substances, with the event classified as accidental and documented in a follow-up visit. The term "other" indicates the substance is not specified elsewhere in the ICD-10-CM classification, and "subsequent encounter" denotes care after the acute phase of treatment.

Causes

Accidental exposure to other drugs or biological substances can result from unintended ingestion, therapeutic error (e.g., incorrect dosing), or environmental contact with substances not categorized under more detailed codes. The cause may be unknown or unspecified, particularly when the substance involved is not identified in the medical record.

Risk Factors

  • Concurrent use of multiple medications increasing interaction risk
  • History of substance misuse or self-harm behaviors
  • Lack of supervision in medication administration (e.g., in vulnerable populations)
  • Underlying conditions requiring drug therapy
  • Polypharmacy (use of multiple medications)

Symptoms

Symptoms can vary widely depending on the substances involved but may include:

  • Gastrointestinal disturbances (nausea, vomiting, diarrhea)
  • Neurological effects (dizziness, confusion, altered mental status)
  • Cardiovascular instability (hypotension, arrhythmias)
  • Respiratory depression or distress
  • Skin reactions (rash, itching, or discoloration)

Diagnosis

Diagnosis involves clinical evaluation of symptoms, patient history (including possible exposure), and laboratory testing (e.g., toxicology screens) to identify the substance involved. Documentation must confirm the event as accidental and specify it is a subsequent encounter. Imaging or other tests may be used to assess organ damage or complications.

Treatment Options

Treatment focuses on stabilizing the patient, removing the substance (e.g., gastric lavage, activated charcoal), and managing symptoms. Supportive care (e.g., IV fluids, respiratory support) and specific antidotes (if available) may be administered. Follow-up care addresses any residual effects or complications from the poisoning.

Prognosis and Follow-Up

Prognosis depends on the substance, dose, and timeliness of treatment. Most patients recover with appropriate care, but severe cases may result in long-term organ damage. Follow-up care monitors for delayed effects, ensures adherence to safety measures, and addresses any underlying risks (e.g., medication management).

Complications

Potential complications include organ damage (e.g., liver or kidney failure), respiratory failure, seizures, or cardiovascular collapse. Long-term effects may occur if the substance causes chronic toxicity or if treatment is delayed.

Lifestyle & Prevention

  • Store medications securely to prevent accidental access.
  • Follow dosing instructions carefully and avoid mixing medications without guidance.
  • Educate patients and caregivers on proper medication handling and disposal.
  • Use childproof containers and supervise administration in vulnerable populations.

When to Seek Professional Help

Seek immediate medical attention if accidental exposure to a drug or substance is suspected, especially with symptoms like difficulty breathing, severe dizziness, or altered consciousness. Follow-up care is necessary for ongoing symptoms or complications after initial treatment.

Tips for Medical Coders

Document the accidental nature of the poisoning and confirm it is a subsequent encounter. Ensure the substance is classified as "other" (not specified elsewhere) and that the encounter occurs after the acute phase of treatment. Code T50.991D requires clear documentation of the event type and encounter status to support accurate reporting.

Book a walkthrough

T50.991D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.